April 21 (Reuters) - Moderna said on Tuesday the European Commission had approved its combination vaccine for the prevention of influenza and COVID-19 in adults 50 years of age and older. Here are the details: • The approval follows a positive recommendation from the European Medicines Agency,

Both the seasonal flu vaccine and the updated COVID-19 vaccine are recommended annually for nearly everyone ages 6 months and older to prevent severe respiratory illness, hospitalizations, and death. You can safely receive both vaccines during the same ...

Older adults across the European Union are a step closer to replacing two annual jabs with one. In late February 2026, the European Medicines Agency’s expert committee recommended approval of Moderna’s mCombriax,